Diaclone

Human Granzyme B ELISpot Set

Product Code:
 
856.131.020
Product Group:
 
ELISpot Kits
Supplier:
 
Diaclone
Host Type:
 
Human
Regulatory Status:
 
RUO
Application:
 
ELISpot
 

No additional charges, what you see is what you pay! *

CodeSizePrice
856.131.02020 x 96 (plates not included)£1,151.00
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: France.
Typical lead time: 14-21 working days.
Contact us for more accurate information.
  • Further Information
  • References
  • Show All

Further Information

Additional 2:
Spots read visually or with reader
Description:
Diaclone ELISpot Sets include capture and detection antibodies Streptavidin - Alkaline Phosphatase conjugated BSA BCIP/NTB blocking reagent.
Detection Target:
Granzyme B
Incubation:
3h after cell stimulation
Reactivity:
Human
Research Area:
Cytotoxic Molecules
Specificity:
Recognizes natural human Granzyme B

References

  1. Biagi E. et al. Blood 2005; 105(6): 2436 - 2442. Molecular transfer of CD40 and OX40 ligands to leukemic human B cells induces expansion of autologous tumor-reactive cytotoxic T lymphocytes. https://www.ncbi.nlm.nih.gov/pubmed/15536147
  2. Godard B. et al. Hum. Immunol. 2004; 65(11): 1307-18. Optimization of an elispot assay to detect cytomegalovirus-specific CD8+ T lymphocytes.. https://www.ncbi.nlm.nih.gov/pubmed/15556681
  3. Lindner S. et al. Cancer Res.2013; 73(8): 2468-2479. Interleukin 21-Induced Granzyme B-Expressing B Cells Infiltrate Tumors and Regulate T Cells. https://www.ncbi.nlm.nih.gov/pubmed/23384943
  4. Thalmensi J. et al.Oncoimmunology2016; 5(3): e1083670.. Anticancer DNA vaccine based on human telomerase reverse transcriptase generates a strong and specific T cell immune response.. https://www.ncbi.nlm.nih.gov/pubmed/27141336
  5. Biagi E. et al. Blood 2005; 105(6): 2436 - 2442. Molecular transfer of CD40 and OX40 ligands to leukemic human B cells induces expansion of autologous tumor-reactive cytotoxic T lymphocytes. https://www.ncbi.nlm.nih.gov/pubmed/15536147
  6. Godard B. et al. Hum. Immunol. 2004; 65(11): 1307-18. Optimization of an elispot assay to detect cytomegalovirus-specific CD8+ T lymphocytes.. https://www.ncbi.nlm.nih.gov/pubmed/15556681